Approaching Treatment-Resistant Depression in Adolescents
Please use the self-sign-up link and code "OnDemand2026" to create an account on our CE Portal. If this is your first time accessing our portal, you will receive a confirmation email from ERC and Pathlight Continuing Education Events with a link to log in. If you have an existing account, once you’ve completed the self-sign-up form, you can log directly into your account to access the webinar.
Download our instructional PDF.
Many adolescents do not respond to first- and second-line treatments for depression, and there is limited research data to guide treatment beyond this point. Through studies such as the Treatment of Adolescent Depression Study (TADS) and the Treatment of Resistant Depression in Adolescents (TORDIA) study, we understand typical response rates and factors associated with non-response to treatment. Clinicians can learn to identify and address these factors, which may increase the likelihood of treatment response. Furthermore, there are several interventional approaches such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and ketamine, that have emerging evidence in youth suggesting favorable response rates in treatment-resistant depression.
The target audience for this continuing education program is mental health providers and clinicians working with individuals with mental health diagnoses. Materials are appropriate for learners with an introductory level of understanding about mental health concerns.
Educational Objectives:
Following this presentation, participants will be able to…
- Identify and describe treatment-resistant depression in youth
- Identify factors associated with treatment resistance in their patients
Describe therapeutic approaches to treatment-resistant depression
If you have questions about this event, or need more information, please reach out to [email protected]